-
Share
16/05/17
10:44
Share
Gearing themselves for a tilt at the medicinal marijuana market on both ends.
Do you really think they'd goto the trouble of appointing one of the founders of CAN as a director of the subsidiary to assist with deals?
Don't forget how tightly held this stock is with both directors owning a massive chunk of the company
-